On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
Enhertu first secured approval in 2019 for patients with high levels of HER2, a protein that promotes cancer cell growth. In ...
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
7d
In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback